Function and dysfunction of α-synuclein: Probing conformational changes and aggregation by single molecule fluorescence

Molecular Neurobiology

Volumn 47, Issue 2, 2013, Pages 622-631

  Trexler, Adam J ^a   Rhoades, Elizabeth ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

Aggregation; Amyloid; Oligomers; Parkinson s disease; Single molecule fluorescence

Indexed keywords

ALPHA SYNUCLEIN; OLIGOMER;

ARTICLE; CONFORMATIONAL TRANSITION; FLUORESCENCE ANALYSIS; FLUORESCENCE CORRELATION SPECTROSCOPY; HUMAN; MEMBRANE BINDING; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; REGULATORY MECHANISM; SINGLE-MOLECULE FLUORESCENCE; ANIMAL; CHEMISTRY; PHYSIOLOGY; PROCEDURES; PROTEIN CONFORMATION; SPECTROFLUOROMETRY; STRUCTURE ACTIVITY RELATION; METHODOLOGY; REVIEW;

ALPHA-SYNUCLEIN; ANIMALS; HUMANS; PROTEIN CONFORMATION; PROTEIN FOLDING; SPECTROMETRY, FLUORESCENCE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84877686577     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-012-8338-x     Document Type: Article

References (96)

1. Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, del Ser T, Munoz DG, de Yebenes JG (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55(2):164-173
2. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease. Nat Genet 18(2):106-108
3. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276(5321):2045-2047
4. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) Alpha-synuclein locus triplication causes Parkinson’s disease. Science 302(5646):841
5. Bartels T, Choi JG, Selkoe DJ (2011) Alpha-synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477(7362):107-110
6. Wang W, Perovic I, Chittuluru J, Kaganovich A, Nguyen LT, Liao J, Auclair JR, Johnson D, Landeru A, Simorellis AK, Ju S, Cookson MR, Asturias FJ, Agar JN, Webb BN, Kang C, Ringe D, Petsko GA, Pochapsky TC, Hoang QQ (2011) A soluble alphasynuclein construct forms a dynamic tetramer. Proc Natl Acad Sci U S A 108(43):17797-17802
7. Eliezer D, Kutluay E, Bussell R Jr, Browne G (2001) Conformational properties of alpha-synuclein in its free and lipid-associated states. J Mol Biol 307(4):1061-1073
8. Cooper AA, Gitler AD, Cashikar A, Haynes CM, Hill KJ, Bhullar B, Liu KN, Xu KX, Strathearn KE, Liu F, Cao SS, Caldwell KA, Caldwell GA, Marsischky G, Kolodner RD, LaBaer J, Rochet JC, Bonini NM, Lindquist S (2006) Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson’s models. Science 313(5785):324-328
9. Outeiro TF, Putcha P, Tetzlaff JE, Spoelgen R, Koker M, Carvalho F, Hyman BT, McLean PJ (2008) Formation of toxic oligomeric alpha-synuclein species in living cells. PLoS One 3(4):e1867
10. Murphy DD, Rueter SM, Trojanowski JQ, Lee VM (2000) Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci 20(9):3214-3220
11. Kahle PJ, Neumann M, Ozmen L, Haass C (2000) Physiology and pathophysiology of alpha-synuclein. Cell culture and transgenic animal models based on a Parkinson’s disease-associated protein. Ann N Y Acad Sci 920:33-41
12. Gitler AD, Bevis BJ, Shorter J, Strathearn KE, Hamamichi S, Su LJ, Caldwell KA, Caldwell GA, Rochet JC, McCaffery JM, Barlowe C, Lindquist S (2008) The Parkinson’s disease protein alphasynuclein disrupts cellular Rab homeostasis. Proc Natl Acad Sci U S A 105(1):145-150
13. Nemani VM, Lu W, Berge V, Nakamura K, Onoa B, Lee MK, Chaudhry FA, Nicoll RA, Edwards RH (2010) Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65(1):66-79
14. Thayanidhi N, Helm JR, Nycz DC, Bentley M, Liang YJ, Hay JC (2010) Alpha-synuclein delays endoplasmic reticulum (ER)-to-Golgi transport in mammalian cells by antagonizing ER/Golgi SNAREs. Mol Biol Cell 21(11):1850-1863
15. Jensen PH, Nielsen MS, Jakes R, Dotti CG, Goedert M (1998) Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson’s disease mutation. J Biol Chem 273 (41):26292-26294
16. Bodner CR, Maltsev AS, Dobson CM, Bax A (2010) Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson’s disease revealed by solution NMR spectroscopy. Biochemistry 49(5):862-871
17. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide. Nat Rev Mol Cell Biol 8(2):101-112
18. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300(5618):486-489
19. Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, Walz T, Lansbury PT Jr (2002) Alpha-synuclein, especially the Parkinson’s disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol 322(5):1089-1102
20. Giehm L, Svergun DI, Otzen DE, Vestergaard B (2011) Lowresolution structure of a vesicle disrupting α-synuclein oligomer that accumulates during fibrillation. Proc Natl Acad Sci U S A: 3246-3251
21. van Rooijen BD, Claessens MMAE, Subramaniam V (2010) Membrane permeabilization by oligomeric α-synuclein: in search of the mechanism. PLoS One 5:e14292
22. Yu J, Lyubchenko YL (2009) Early stages for Parkinson’s development: alpha-synuclein misfolding and aggregation. J Neuroimmune Pharmacol 4(1):10-16
23. Sandal M, Valle F, Tessari I, Mammi S, Bergantino E, Musiani F, Brucale M, Bubacco L, Samori B (2008) Conformational equilibria in monomeric alpha-synuclein at the single-molecule level. PLoS Biol 6(1):e6
24. Losasso V, Pietropaolo A, Zannoni C, Gustincich S, Carloni P (2011) Structural role of compensatory amino acid replacements in the alpha-synuclein protein. Biochemistry 50(32):6994-7001
25. Tsigelny IF, Sharikov Y, Miller MA, Masliah E (2008) Mechanism of alpha-synuclein oligomerization and membrane interaction: theoretical approach to unstructured proteins studies. Nanomedicine 4 (4):350-357
26. Yoon J, Jang S, Lee K, Shin S (2009) Simulation studies on the stabilities of aggregates formed by fibril-forming segments of alpha-synuclein. J Biomol Struct Dyn 27(3):259-270
27. Ferreon AC, Gambin Y, Lemke EA, Deniz AA (2009) Interplay of alpha-synuclein binding and conformational switching probed by single-molecule fluorescence. Proc Natl Acad Sci U S A 106 (14):5645-5650
28. Ferreon AC, Moran CR, Ferreon JC, Deniz AA (2010) Alteration of the alpha-synuclein folding landscape by a mutation related to Parkinson’s disease. Angew Chem 49(20):3469-3472
29. Gambin Y, VanDelinder V, Ferreon AC, Lemke EA, Groisman A, Deniz AA (2011) Visualizing a one-way protein encounter complex by ultrafast single-molecule mixing. Nat Methods 8(3):239-241
30. Vandelinder V, Ferreon AC, Gambin Y, Deniz AA, Groisman A (2009) High-resolution temperature-concentration diagram of alpha-synuclein conformation obtained from a single Förster resonance energy transfer image in a microfluidic device. Anal Chem 81(16):6929-6935
31. Ferreon AC, Deniz AA (2007) Alpha-synuclein multistate folding thermodynamics: implications for protein misfolding and aggregation. Biochemistry 46(15):4499-4509
32. Chen H, Rhoades E (2008) Fluorescence characterization of denatured proteins. Curr Opin Struct Biol 18(4):516-524
33. Ferreon AC, Moran CR, Gambin Y, Deniz AA (2010) Singlemolecule fluorescence studies of intrinsically disordered proteins. Methods Enzymol 472:179-204
34. Schuler B, Eaton WA (2008) Protein folding studied by singlemolecule FRET. Curr Opin Struct Biol 18(1):16-26
35. Trexler AJ, Rhoades E (2010) Single molecule characterization of alpha-synuclein in aggregation-prone states. Biophys J 99 (9):3048-3055
36. Sherman E, Haran G (2006) Coil-globule transition in the denatured state of a small protein. Proc Natl Acad Sci U S A 103 (31):11539-11543
37. Davidson WS, Jonas A, Clayton DF, George JM (1998) Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273(16):9443-9449
38. Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT Jr (1996) NACP, a protein implicated in Alzheimer’s disease and learning, is natively unfolded. Biochemistry 35(43):13709-13715
39. Ulmer TS, Bax A, Cole NB, Nussbaum RL (2005) Structure and dynamics of micelle-bound human alpha-synuclein. J Biol Chem 280(10):9595-9603
40. Bussell R Jr, Eliezer D (2003) A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins. J Mol Biol 329(4):763-778
41. Georgieva ER, Ramlall TF, Borbat PP, Freed JH, Eliezer D (2008) Membrane-bound alpha-synuclein forms an extended helix: longdistance pulsed ESR measurements using vesicles, bicelles, and rodlike micelles. J Am Chem Soc 130(39):12856-12857
42. Jao CC, Der-Sarkissian A, Chen J, Langen R (2004) Structure of membrane-bound alpha-synuclein studied by site-directed spin labeling. Proc Natl Acad Sci U S A 101(22):8331-8336
43. Jao CC, Hegde BG, Chen J, Haworth IS, Langen R (2008) Structure of membrane-bound alpha-synuclein from site-directed spin labeling and computational refinement. Proc Natl Acad Sci U S A 105(50):19666-19671
44. Borbat P, Ramlall TF, Freed JH, Eliezer D (2006) Inter-helix distances in lysophospholipid micelle-bound alpha-synuclein from pulsed ESR measurements. J Am Chem Soc 128 (31):10004-10005
45. Chandra S, Chen X, Rizo J, Jahn R, Sudhof TC (2003) A broken alpha-helix in folded alpha-synuclein. J Biol Chem 278 (17):15313-15318
46. Drescher M, van Rooijen BD, Veldhuis G, Subramaniam V, Huber M. A stable lipid-induced aggregate of alpha-synuclein. J Am Chem Soc 132(12): 4080-4082
47. Veldhuis G, Segers-Nolten I, Ferlemann E, Subramaniam V (2009) Single-molecule FRET reveals structural heterogeneity of SDSbound alpha-synuclein. ChemBioChem 10(3):436-439
48. Trexler AJ, Rhoades E (2009) Alpha-synuclein binds large unilamellar vesicles as an extended helix. Biochemistry 48(11):2304-2306
49. Nath A, Trexler AJ, Koo P, Miranker AD, Atkins WM, Rhoades E (2010) Single-molecule fluorescence spectroscopy using phospholipid bilayer nanodiscs. Methods Enzymol 472:89-117
50. Giehm L, Oliveira CL, Christiansen G, Pedersen JS, Otzen DE (2010) SDS-induced fibrillation of alpha-synuclein: an alternative fibrillation pathway. J Mol Biol 401(1):115-133
51. Lee HJ, Choi C, Lee SJ (2002) Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J Biol Chem 277(1):671-678
52. Zhu M, Fink AL (2003) Lipid binding inhibits alpha-synuclein fibril formation. J Biol Chem 278(19):16873-16877
53. Zhu M, Li J, Fink AL (2003) The association of alpha-synuclein with membranes affects bilayer structure, stability, and fibril formation. J Biol Chem 278(41):40186-40197
54. Comellas G, Lemkau LR, Zhou DH, George JM, Rienstra CM (2012) Structural intermediates during alpha-synuclein fibrillogenesis on phospholipid vesicles. J Am Chem Soc 134(11):5090-5099
55. Sevcsik E, Trexler AJ, Dunn JM, Rhoades E (2011) Allostery in a disordered protein: oxidative modifications to alpha-synuclein act distally to regulate membrane binding. J Am Chem Soc 133 (18):7152-7158
56. Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM (2000) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290(5493):985-989
57. Conway KA, Rochet JC, Bieganski RM, Lansbury PT Jr (2001) Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294(5545):1346-1349
58. Kaylor J, Bodner N, Edridge S, Yamin G, Hong DP, Fink AL (2005) Characterization of oligomeric intermediates in alphasynuclein fibrillation: FRET studies of Y125W/Y133F/Y136F alpha-synuclein. J Mol Biol 353(2):357-372
59. Volles MJ, Lee SJ, Rochet JC, Shtilerman MD, Ding TT, Kessler JC, Lansbury PT Jr (2001) Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson’s disease. Biochemistry 40(26):7812-7819
60. Zakharov SD, Hulleman JD, Dutseva EA, Antonenko YN, Rochet JC, Cramer WA (2007) Helical alpha-synuclein forms highly conductive ion channels. Biochemistry 46(50):14369-14379
61. Glabe CG (2008) Structural classification of toxic amyloid oligomers. J Biol Chem 283(44):29639-29643
62. Kayed R, Pensalfini A, Margol L, Sokolov Y, Sarsoza F, Head E, Hall J, Glabe C (2009) Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer. J Biol Chem 284 (7):4230-4237
63. Nath S, Meuvis J, Hendrix J, Carl SA, Engelborghs Y (2010) Early aggregation steps in alpha-synuclein as measured by FCS and FRET: evidence for a contagious conformational change. Biophys J 98(7):1302-1311
64. Bisaglia M, Mammi S, Bubacco L (2009) Structural insights on physiological functions and pathological effects of alphasynuclein. FASEB J 23(2):329-340
65. Fink AL (2006) The aggregation and fibrillation of alpha-synuclein. Acc Chem Res 39(9):628-634
66. Bieschke J, Russ J, Friedrich RP, Ehrnhoefer DE, Wobst H, Neugebauer K, Wanker EE (2010) EGCG remodels mature alphasynuclein and amyloid-beta fibrils and reduces cellular toxicity. Proc Natl Acad Sci U S A 107(17):7710-7715
67. Conway KA, Lee SJ, Rochet JC, Ding TT, Harper JD, Williamson RE, Lansbury PT Jr (2000) Accelerated oligomerization by Parkinson’s disease linked alpha-synuclein mutants. Ann N Y Acad Sci 920:42-45
68. Walsh DM, Selkoe DJ (2004) Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. Protein Pept Lett 11(3):213-228
69. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani M (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416(6880):507-511
70. Kagan BL, Hirakura Y, Azimov R, Azimova R, Lin MC (2002) The channel hypothesis of Alzheimer’s disease: current status. Peptides 23(7):1311-1315
71. Ono K, Condron MM, Teplow DB (2009) Structure-neurotoxicity relationships of amyloid beta-protein oligomers. Proc Natl Acad Sci U S A 106(35):14745-14750
72. Sharon R, Bar-Joseph I, Frosch MP, Walsh DM, Hamilton JA, Selkoe DJ (2003) The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson’s disease. Neuron 37(4):583-595
73. Sharon R, Goldberg MS, Bar-Josef I, Betensky RA, Shen J, Selkoe DJ (2001) Alpha-synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins. Proc Natl Acad Sci U S A 98 (16):9110-9115
74. Yamin G, Uversky VN, Fink AL (2003) Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers. FEBS Lett 542(1-3):147-152
75. Uversky VN, Yamin G, Munishkina LA, Karymov MA, Millett IS, Doniach S, Lyubchenko YL, Fink AL (2005) Effects of nitration on the structure and aggregation of alpha-synuclein. Brain Res Mol Brain Res 134(1):84-102
76. Uversky VN, Yamin G, Souillac PO, Goers J, Glaser CB, Fink AL (2002) Methionine oxidation inhibits fibrillation of human alphasynuclein in vitro. FEBS Lett 517(1-3):239-244
77. Cole NB, Murphy DD, Lebowitz J, Di Noto L, Levine RL, Nussbaum RL (2005) Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments. J Biol Chem 280(10):9678-9690
78. Nielsen MS, Vorum H, Lindersson E, Jensen PH (2001) Ca2+ binding to alpha-synuclein regulates ligand binding and oligomerization. J Biol Chem 276(25):22680-22684
79. Kostka M, Hogen T, Danzer KM, Levin J, Habeck M, Wirth A, Wagner R, Glabe CG, Finger S, Heinzelmann U, Garidel P, Duan W, Ross CA, Kretzschmar H, Giese A (2008) Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers. J Biol Chem 283(16):10992-11003
80. Pham CL, Leong SL, Ali FE, Kenche VB, Hill AF, Gras SL, Barnham KJ, Cappai R (2009) Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct onpathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner. J Mol Biol 387(3):771-785
81. Zhou W, Gallagher A, Hong DP, Long C, Fink AL, Uversky VN (2009) At low concentrations, 3,4-dihydroxyphenylacetic acid (DOPAC) binds non-covalently to alpha-synuclein and prevents its fibrillation. J Mol Biol 388(3):597-610
82. Giese A, Bader B, Bieschke J, Schaffar G, Odoy S, Kahle PJ, Haass C, Kretzschmar H (2005) Single particle detection and characterization of synuclein co-aggregation. Biochem Biophys Res Commun 333(4):1202-1210
83. Elson EL, Magde D (1974) Fluorescence correlation spectroscopy. 1. Conceptual basis and theory. Biopolymers 13:1-27
84. Magde D, Elson EL, Webb WW (1974) Fluorescence correlation spectroscopy. II. An experimental realization. Biopolymers 13 (1):29-61
85. Magde D, Webb WW, Elson E (1972) Thermodynamic fluctuations in a reacting system—measurement by fluorescence correlation spectroscopy. Phys Rev Lett 29:705-708
86. Elson EL (2011) Fluorescence correlation spectroscopy: past, present, future. Biophys J 101(12):2855-2870
87. Bacia K, Schwille P (2007) Practical guidelines for dual-color fluorescence cross-correlation spectroscopy. Nat Protoc 2 (11):2842-2856
88. Haustein E, Schwille P (2007) Fluorescence correlation spectroscopy: novel variations of an established technique. Annu Rev Biophys Biomol Struct 36:151-169
89. Bieschke J, Giese A, Schulz-Schaeffer W, Zerr I, Poser S, Eigen M, Kretzschmar H (2000) Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. Proc Natl Acad Sci U S A 97(10):5468-5473
90. Kask P, Palo K, Ullmann D, Gall K (1999) Fluorescence-intensity distribution analysis and its application in biomolecular detection technology. Proc Natl Acad Sci U S A 96(24):13756-13761
91. Gerard M, Debyser Z, Desender L, Kahle PJ, Baert J, Baekelandt V, Engelborghs Y (2006) The aggregation of alpha-synuclein is stimulated by FK506 binding proteins as shown by fluorescence correlation spectroscopy. FASEB J 20(3):524-526
92. Levin J, Giese A, Boetzel K, Israel L, Hogen T, Nubling G, Kretzschmar H, Lorenzl S (2009) Increased alpha-synuclein aggregation following limited cleavage by certain matrix metalloproteinases. Exp Neurol 215(1):201-208
93. Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, Giese A, Kretzschmar H, Hengerer B, Kostka M (2007) Different species of alpha-synuclein oligomers induce calcium influx and seeding. J Neurosci 27(34):9220-9232
94. Hillmer AS, Putcha P, Levin J, Hogen T, Hyman BT, Kretzschmar H, McLean PJ, Giese A (2010) Converse modulation of toxic alpha-synuclein oligomers in living cells by N′-benzylidene-benzohydrazide derivates and ferric iron. Biochem Biophys Res Commun 391(1):461-466
95. Caruana M, Hogen T, Levin J, Hillmer A, Giese A, Vassallo N (2011) Inhibition and disaggregation of alpha-synuclein oligomers by natural polyphenolic compounds. FEBS Lett 585(8):1113-1120
96. Nath A, Sammalkorpi MT, DeWitt D, Schreck C, Trexler AJ, Elbaum-Garfinkle S, O’Hern CS, Rhoades E (2012) The conformational ensembles of α-synuclein and tau: combining singlemolecule FRET and simulations. Biophys J (in press)